CRESCENT BIOPHARMA INC. (CBIOXXXX)
Institutional ownership reported to the SEC as of Q2 2026, across 27 quarters.
2
Reporting holders
$8.5M
Reported value
0.0%
Held as options
-1
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Boxer Capital Management, LLC | $8.2M | 453,686 | 0.62% | 2q | HELD |
| Quadrature Capital Ltd | $346.1K | 19,227 | 0.00% | 3q | -8.1%-$30.4K |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2 | $8.5M | 472,913 | 0 | 0 | 1 | 0.0% |
| Q1 2026 | 3 | $15.4M | 835,853 | 1 | 1 | 0 | 0.0% |
| Q4 2025 | 2 | $161.4K | 374,496 | 1 | 0 | 0 | 0.0% |
| Q1 2025 | 1 | $55 | 0 | 1 | 0 | 0 | 100.0% |
| Q4 2024 | 2 | $3.5K | 0 | 1 | 0 | 0 | 100.0% |
| Q3 2024 | 1 | $355 | 0 | 1 | 0 | 0 | 100.0% |
| Q2 2024 | 2 | $61.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q1 2024 | 2 | $225.6K | 0 | 0 | 0 | 0 | 100.0% |
| Q4 2023 | 2 | $173.0K | 0 | 2 | 0 | 0 | 100.0% |
| Q3 2023 | 2 | $10.5K | 0 | 0 | 0 | 0 | 100.0% |
| Q2 2023 | 2 | $47.3K | 0 | 0 | 0 | 0 | 100.0% |
| Q1 2023 | 2 | $32.9K | 0 | 1 | 0 | 0 | 100.0% |
| Q4 2022 | 3 | $542.1K | 0 | 3 | 0 | 0 | 100.0% |
| Q3 2022 | 1 | $6.0K | 0 | 1 | 0 | 0 | 100.0% |
| Q1 2022 | 1 | $8.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q4 2021 | 2 | $348.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q3 2021 | 2 | $585.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q2 2021 | 2 | $234.0K | 0 | 1 | 0 | 0 | 100.0% |
| Q1 2021 | 2 | $91.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q4 2020 | 2 | $351.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q3 2020 | 2 | $144.0K | 0 | 1 | 0 | 0 | 100.0% |
| Q2 2020 | 2 | $496.0K | 0 | 1 | 0 | 0 | 100.0% |
| Q1 2020 | 2 | $16.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q4 2019 | 2 | $112.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q3 2019 | 2 | $70.0K | 0 | 2 | 0 | 0 | 100.0% |
| Q2 2019 | 1 | $72.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q1 2019 | 2 | $913.0K | 0 | 4 | 0 | 0 | 100.0% |